Sepsis can kill even previously healthy people if recognized too late, finds study

More sepsis awareness among the general public and first responders could benefit more people

5:00 AM

Author | Kelly Malcom

ambulance going into hospital
Getty Images

A recent study University of Michigan led study finds that ten percent of patients hospitalized with sepsis were previously healthy—and many of those who ultimately died did so because it was too late to intervene.

The work, led by Rachel Hechtman, M.D., Hallie Prescott, M.D., and their team, focused on healthy patients as a way to tease out the effects of advanced age, comorbidities and other common risk factors on sepsis outcomes.

Using data from 66 hospitals in Michigan from more than 25,000 patients with sepsis, the team identified a subset as previously healthy, lacking major health conditions such as cancer, chronic pulmonary disease and heart failure.

Previously healthy patients tended to have less organ failure upon arrival at the hospital and more COVID-19 related sepsis (the study included data from 11/2020 – 10/2024).

Treatment for these patients differed as well, with less adherence to sepsis management practices, such as blood culture collection and timely delivery of antibiotics.

Those who unfortunately died tended to be older, and had more acute respiratory dysfunction, altered mental status and shock upon admission to the hospital.

During their course of treatment, these patients also received vasopressors and invasive mechanical ventilation more often than survivors, notes the authors.

Most of their deaths were deemed to be unpreventable due to how sick they were when they arrived at the hospital.

Overall, almost 10% of previously healthy patients with sepsis died within 90 days of hospitalization.

The study, notes the team, identifies system level opportunities to reduce the rate of death in patients with sepsis.

“Efforts to increase sepsis awareness among the public and first responders would benefit everyone. Some of these tragic deaths among previously healthy people might have been avoided if their illness had been prevented through vaccination or recognized and treated early before they got sick enough to come to the hospital,” said Hechtman.

Additional authors: Megan E. Heath, Ph.D.; Jennifer K. Horowitz, M.A.; Elizabeth McLaughlin, M.S., RN; Patricia J. Posa, R.N., B.S.N., M.S.A., CCRN; John Blamoun, M.D.; Paul Bozyk, M.D.; Megan Cahill, D.O., M.B.A., FACOEP; Rania Esteitie, M.D., FCCP, ATSF; Kevin Furlong, D.O.; Namita Jayaprakash, MB, BcH BAO, MRCEM; Jessica Jones, PharmD; Maximiliano Tamae-Kakazu, M.D.; Joan Nagelkirk, M.D.; Thomas Pfotenhauer, D.O.; Derek C. Angus, M.D., M.P.H., FRCP; Scott A. Flanders, M.D.; Elizabeth S. Munroe, M.D.

Funding/disclosures: This study was supported by Blue Cross Blue Shield of Michigan and Blue Care Network as part of the Blue Cross Blue Shield of Michigan Value Partnerships program. R. K. H. and H. C. P. were supported by the National Institutes of Health [Grant T32HL007749-31].

Paper cited: “Epidemiologic Characteristics and Management of Sepsis Among Previously Healthy Patients,” CHEST Critical Care. DOI: 10.1016/j.chstcc.2025.100148  


More Articles About:

Sepsis Health Care Delivery, Policy and Economics Patient Safety Emergency & Trauma Care All Research Topics
Health Lab word mark overlaying blue cells

Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

Rachel K. Hechtman

Rachel K Hechtman, MD

Clinical Instructor

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

close up of cells blue purple pink
Health Lab

Researchers create new path to target hard-to-drug prostate cancer protein

University of Michigan researchers have identified a specific pocket within ERG, a driver of prostate cancer, and have developed a small molecule probe, called PBITE-1, that can bind to it.
person holding scale with scrubs on and stethoscope
Health Lab

7 things to know about Medicare’s new GLP-1 coverage

Medicare coverage of GLP-1 drugs for weight loss including Wegovy and Zepbound has begun but has limits.
team standing around person using virtual reality headset
Health Lab

How new care models, within a new building launch, are helping optimize patient care

New care models in a new building opening at Michigan Medicine is helping to optimize patient care.
Health Lab

Path forward for glioblastoma treatment

Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
lights scattered all over blue screen connected
Health Lab

Studying neurons using neurons

Labs at the University of Michigan Medical School are exploring a new technology that leverages the biological capabilities of human neurons for artificial intelligence.
woman looking at screen in office clinical area
Health Lab

How AI is helping emergency physicians learn from their patients

How the “Tell Me What Happens Next” initiative is being used by the Department of Emergency Medicine’s new Division of Clinical Informatics using artificial intelligence.